Drug intelligence / Profile preview

(R)-3-hydroxybutyl (R)-3-hydroxybutyrate

Development stage
Phase 3
Lead developer
University of Oxford
Modality
Small Molecules
Administration
Oral
01

Overview

Exogenous ketone esters are synthetic compounds designed to rapidly induce nutritional ketosis by elevating blood levels of beta-hydroxybutyrate (BHB) without the requirement for fasting or a ketogenic diet. The most extensively studied variant is the monoester **(R)-3-hydroxybutyl (R)-3-hydroxybutyrate**, which was developed through a collaboration between the University of Oxford and the National Institutes of Health (NIH) and is currently commercialized by **TdeltaS Global**. Upon ingestion, the ester is hydrolyzed in the gut and liver into BHB and 1,3-butanediol, the latter of which is further metabolized into BHB. This process provides an alternative energy substrate for the brain, heart, and muscles, and exerts signaling effects through the **hydroxycarboxylic acid receptor 2 (HCAR2)**. Clinical investigations are exploring its utility in treating alcohol use disorder (by reducing cravings and withdrawal symptoms), heart failure with preserved ejection fraction (HFpEF), epilepsy, and metabolic conditions related to appetite regulation.

Brand names
deltaGΔG Tactical KetonesHVMN Ketone
Other names
exogenous ketone esterketone monoesterD-beta-hydroxybutyrate esterOxford Ketone Esterketone ester
02

Targets

MCT2 (Monocarboxylate transporter 2)SLC16A1 (Mitochondrial Pyruvate Carrier)ChREBP-14-3-3 (Carbohydrate response element-binding protein-14-3-3 regulatory axis)

Beyond the preview

Go deeper on (R)-3-hydroxybutyl (R)-3-hydroxybutyrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (R)-3-hydroxybutyl (R)-3-hydroxybutyrate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call